Understanding OUR Cytokine-Based Immunotherapy Candidates Our determination extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where treatment solutions remain limited. Utilize the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Investigate Our P... https://financefeeds.com/xs-com-appoints-stelios-pallis-as-chief-technology-officer/